Viewing Study NCT06743503


Ignite Creation Date: 2025-12-24 @ 7:11 PM
Ignite Modification Date: 2026-02-19 @ 5:31 PM
Study NCT ID: NCT06743503
Status: RECRUITING
Last Update Posted: 2025-09-18
First Post: 2024-12-10
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: UB-VV400 in Combination With Rapamycin in Relapsed or Refractory B-cell Malignancies
Sponsor: Nanjing IASO Biotechnology Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module